SPIRONOLACTONE

Clinical trials for SPIRONOLACTONE explained in plain language.

Never miss a new study

Get alerted when new SPIRONOLACTONE trials appear

Sign up with your email to follow new studies for SPIRONOLACTONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Old diuretic drug shows promise for Autism-Linked gene condition

Symptom relief Completed

This study tested spironolactone, a common diuretic, in 2 children aged 3-10 with NCOR gene mutations and autism. The goal was to see if it could improve learning, memory, and autism symptoms. The drug is already known to be safe in children for other uses.

Matched conditions: SPIRONOLACTONE

Phase: PHASE2, PHASE3 • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief

Last updated May 11, 2026 20:38 UTC

SPIRONOLACTONE

Get alerted when new SPIRONOLACTONE trials appear

Old diuretic drug shows promise for Autism-Linked gene condition